Ursodeoxycholic Acid
Mild
Database
Potentially increased nitrendipine levels and risk of adverse effects (e.g., hypotension).
Monitor blood pressure and for nitrendipine-related adverse effects. Dose adjustment of nitrendipine may be needed.
Drug reference
nitrendipine
Dihydropyridine calcium channel blocker · Antianginal
Dihydropyridine calcium channel blockerAntianginal
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
—
none in our sources
PREGNANCY
—
not curated
Mechanism
Releases NO from the endothelium and inhibits cAMP phosphodiesterase, contributing to vasodilator action. The endothelial NO may retard atherosclerosis. Does not depress ventricular contractility and A-V conduction.
Indications
HypertensionAngina pectoris
Dosing
- Adult
- 5–20 mg OD
Pharmacokinetics
Half-life
4–12 hours
Bioavailability
10–30%
Drug interactions
Related guidelines
Other Dihydropyridine calcium channel blocker drugs
Ask House about nitrendipine
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: KD Tripathi 7e·Verified: 2026-05-10 · House clinical team